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Abstract
The ADAMs are a family of proteins containing multiple functional domains. We have cloned the avian orthologue of ADAM 10 and
demonstrate that it has metalloprotease activity. Chick ADAM 10 is expressed in the developing dermatome and myotome of the somite,
epidermis, gut endoderm, the epithelial tissues of the kidney, liver, and heart, and in neural crest cells. The expression patterns and protein
distribution of ADAM 10 suggest it may play a significant role in the morphogenesis of several epithelial tissues. When a dominant-negative
metalloprotease-mutant form of ADAM 10 is expressed in the ectoderm or ADAM 10 expression is knocked down with morpholinos,
morphogenesis and tissue specification are altered.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Multiple cellular functions regulate morphogenetic
movements during embryogenesis. Migratory cells must be
able to adhere to a substratum to promote tractional force.
Generally, they adhere to extracellular matrix molecules by
way of cell-surface receptors in the integrin superfamily
(Holly et al., 2000; Hynes, 1992). These same cells must
also detach from the substratum to make forward progress,
and there is considerable evidence that cell-surface pro-
teases are required for this detachment (Chang and Werb,
2001).
The ADAMs (A Disintegrin And Metalloprotease) are a
family of transmembrane proteins with extracellular metal-
loprotease, disintegrin, and cysteine-rich domains (Wolfs-
berg et al., 1995a,b). This multifunctionality makes them
ideal candidates for regulating cell motility. Several ADAMs
contain a conserved metalloprotease active site and exhibit
protease activity (Black et al., 1997; Izumi et al., 1998;
Moss et al., 1997). ADAMs may regulate cell–cell or cell–
matrix adhesions via proteolytic activity or by interactions
between their disintegrin domains and integrin proteins.
Data suggest that multiple regions of the disintegrin domain
of ADAMs interact with integrin proteins, allowing for
promiscuous ADAM-integrin interactions (Eto et al., 2000;
Nath et al., 2000; Zhang et al., 1998; Zhou et al., 2001). The
cytoplasmic domains of many ADAM family members
have binding sites for SH3 domain-containing proteins, and
therefore, may exhibit signaling capability (Howard et al.,
1999; Kang et al., 2000; Suzuki et al., 2000; Weskamp et
al., 1996).
The developmental significance of the ADAM proteins
has been explored for only a few family members. Fertilin-
is required for normal sperm–egg interactions (Cho et al.,
1998), and ADAM 17 is required for proper epithelial tissue
development in mice (Peschon et al., 1998). ADAM 13 is
expressed in somites and cranial neural crest cells during
Xenopus development (Alfandari et al., 1997) and is re-
quired for proper cranial neural crest cell migration (Alfan-
dari et al., 2001).
Finally, ADAM 10/Kuzbanian (Kuz) is important during
neuronal development in vertebrates and Drosophila. Kuz
proteolytically cleaves the Notch ligand, Delta (Qi et al.,
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1999), and is essential for neuronal specification in Dro-
sophila (Rooke et al., 1996). Expression of a dominant-
negative form of ADAM 10 in vertebrate embryos results in
an overabundance of neural cell types, suggesting ADAM
10 is also required for vertebrate neuronal specification and
proper signaling through the Notch pathway (Pan and Ru-
bin, 1997). Kuz also controls growth cone function during
later development; expression of a dominant-negative form
of Kuz results in improper axon extension and abnormal
crossing of the CNS midline (Fambrough et al., 1996;
Schimmelpfeng et al., 2001). ADAM 10 also displays col-
lagenase activity (Millichip et al., 1998), which may play a
role in cell migration and invasion during morphogenesis.
Thus, ADAM 10 is clearly important in tissue morphogen-
esis and differentiation during development.
We have cloned the chick orthologue of ADAM 10.
ADAM 10 mRNA and protein are especially prominent in
the epidermis, the somitic dermatome and myotome, kidney
tubules, and the endocardium and myocardium of the heart,
which are all epithelial tissues. In addition, ADAM 10
protein is detected in the epicardium of the heart, the gut
endoderm, the liver, and in mesenchymal cells that have
undergone an epithelial-to-mesenchymal transformation
(EMT), including endocardial cushion cells and dermis.
ADAM 10 is also expressed by neural crest cells in culture.
Chick ADAM 10 was demonstrated to have metalloprotease
activity by zymography of chick brain extracts, as well as
during development when we expressed a dominant-nega-
tive ADAM 10 metalloprotease-mutant construct. The ex-
pression patterns and functional analysis of chick ADAM
10 suggest it may have important roles in cell specification,
tissue remodeling, and morphogenesis during development,
especially of the epithelial lineages.
Materials and methods
Cloning of chick ADAM 10
Degenerate RT-PCR was performed to obtain avian
ADAM 10. Day 9 embryonic chick brain mRNA was pu-
rified using the Micro-Fast Track mRNA isolation kit (In-
vitrogen), and RT-PCR was performed with degenerate
primers (Gibco-BRL) based on an alignment of mammalian
ADAM 10 sequences and the Drosophila kuz sequence (K1B;
5-GA(A/G)GA(A/G)TG(C/T)GA(C/T)TG(C/T)GG-3,
Fig. 1. Deduced protein sequence for chick ADAM 10, aligned with the amino acid sequences of mouse and bovine ADAM 10. The cysteine predicted to
function as a cysteine-switch is marked with an asterisk. The furin cleavage site (RKKR) is underlined in bold. The metalloprotease active site is shown in
black shading. Potential N-glycosylation sites are shaded in dark gray with white lettering. The predicted transmembrane domain is bold italicized. The cDNA
sequence for chick ADAM 10 has been deposited with GenBank under Accession No. AY077631.
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K3C; 5-GAANAC(A/G)TC(A/G)CAGTA(A/G)CC-3).
PCR amplifications contained 100 ng of each primer, 10
mM dNTPs, and 0.5 U Taq polymerase in standard buffer
with Mg2 (Promega) for 30 cycles (1 min at 94°C, 1 min
at 50°C, 1 min at 72°C). Nested PCR was then carried out
(K2B; 5-(A/T)(C/G)NCA(A/G)GGNCCNTG(C/T)TG-3,
and primer K3C) for 30 cycles (1 min at 94°C, 1 min at
55°C, 1 min at 72°C). A 410-bp product was amplified from
this nested reaction and cloned into the pCRII vector (In-
vitrogen). DNA was sequenced by the UC Davis sequencing
facility. Chick ADAM 10 was subsequently subcloned into
the EcoR1 site of pBluescript SK for preparation of ribo-
probe.
To obtain the full-length ADAM 10 cDNA sequence,
RACE-PCR was performed with embryonic day 11 chick
brain cDNA using the Marathon cDNA amplification kit and
the SMART-RACE cDNA amplification kit (Clontech).
RACE-PCR was carried out with 10 mmol of oligonucleotide
(Operon) (RACDISR; 5ACATTCCCTCCCTCGCACAGTCC-
3, RACDISF2; 5-CGACTTGGAGGAATGCACATGCGC-
3, R10R2; 5GGGAGGAACATGAGAGCCATAGTTC-3,
5R4F; 5TGTGCAATTACAGCTTCCCTTGTTCCA-3;
5RF2; 5GCATGAAAGTCGAGGCGCAAGAACTGA-3,
3RF2; 5-TCAGTTCTTGCGCCTCGACTTTCATGC-3).
All PCR products were cloned into the pCRII vector (In-
vitrogen) and sequenced at either the UC Davis sequencing
facility or Davis Sequencing (Davis, CA). ADAM 10 clones
were aligned at the CLUSTALW web site (http://
dot.imgen.bcm.tmc.edu:9331/multi-align/Options/
clustalw.html).
Northern hybridization
Total RNA was extracted from whole-chick embryos at
day 2, 3, 4, and 5, and from day 5 and day 10 eye, day 10
brain, and day 10 heart. RNA was also harvested from quail
melanoblast cultures. Twenty micrograms of RNA was
loaded per well on a formaldehyde gel, and Northern trans-
fer and hybridization were performed following the protocol
of Tucker et al. (1997).
Whole-mount in situ hybridization
Whole-mount in situ hybridization followed the protocol
of Nieto et al. (1996), with the following changes: (1)
Tissue was bleached with 3% hydrogen peroxide in 100%
methanol overnight at 4°C. (2) Embryos were hybridized
for 40 h at 68°C. (3) Two posthybridization washes were
used (wash 1: 50% formamide, 5 SSC pH 4.5, 1% SDS,
68°C; wash 2: 50% formamide, 2 SSC pH 4.5, 0.5% SDS,
65°C). (4) Ten percent goat serum (Gibco-BRL) was used
as a blocking agent for the antibody incubation. (5) Em-
bryos were incubated with the anti-digoxigenin (DIG) an-
tibody (Roche) in 10% goat serum/TTBST (100 mM Tris
pH 7.5, 150 mM NaCl, 0.5% Triton X-100, 0.1% Tween 20)
for 40 h at 4°C. (6) Postantibody washes were performed
with TTBST. (7) Embryos were developed at room temper-
ature in AP buffer (100 mM Tris pH 9.5, 100 mM NaCl, 50
mM MgCl2) containing Fast Red (Sigma). ADAM 10 ribo-
probe was generated with linearized chick ADAM 10
cDNA in pBluescript SK and DIG-labeled nucleotides
(Roche). T3 and T7 RNA polymerases (Promega) were used
to produce sense and antisense riboprobes. Sense riboprobe
served as a control for nonspecific hybridization.
Embryos were washed in PBS, fixed in 4% paraformal-
dehyde, washed in PBS again, infiltrated with 20% sucrose,
and embedded in Tissue Tek (Fisher). Thirty-micron cryo-
sections were cut and mounted with Gel/Mount (Fisher).
Sections were viewed with a Leitz Dialux 20 fluorescence
Fig. 2. Expression of ADAM 10 in different embryonic tissues and cultured cells. (a) Northern blot of ADAM 10 mRNA. Total RNA was extracted from
embryonic chick tissues and cultured quail melanoblasts, and 20 g RNA was loaded per lane. (1) Day 2 whole embryo, (2) day 3 whole embryo, (3) day
4 whole embryo, (4) day 5 whole embryo, (5) day 5 eye, (6) day 10 eye, (7) day 10 brain, (8) day 10 heart, (9) quail melanoblasts. (b) Ethidium
bromide-stained filter utilized for Northern blotting, showing equal loading of RNA per lane.
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microscope and images were captured with an Optronics
Magnafire digital camera.
ADAM 10 antibodies
We generated a rabbit polyclonal peptide antibody to a
portion of the disintegrin domain (aa 486–496) of chick
ADAM 10 (Chiron Technologies). Three bleeds were col-
lected from two rabbits immunized with the chick ADAM
10 peptide. One bleed, 3210(3), was utilized for all of the
data presented here. A polyclonal peptide antibody corre-
sponding to amino acids 732–748 of human ADAM 10 was
obtained from Chemicon.
Western transfer and blotting
To determine antibody specificity, Western blotting was
performed with the human ADAM 10 antibody. Glycopro-
teins from adult chicken brains (Pel-Freez Biological) were
partially purified using lentil-lectin Sepharose chromatog-
raphy (see Millichip et al., 1998). After elution from the
lentil–lectin column, protein was concentrated using Cen-
tricon Plus-20 filters (Millipore). The protein extracts were
separated by SDS–PAGE (Ready-gels, Bio-Rad), and pro-
tein was then transferred to PVDF transfer membrane
(NEN). The membrane was washed in TTBST (100 mM
Tris– HCl pH 7.4, 150 mM NaCl, 0.1% Tween 20), and
blocked overnight in 5% nonfat dry milk in TTBST at 4°C.
The chick or human ADAM 10 antibody (1:500) was then
added in block solution and the filter incubated at room
temperature for 1 h. The filter was then washed, blocked
again, and incubated for 1 h at room temperature with
goat anti-rabbit alkaline phosphatase secondary antibody
(1:3000; Santa Cruz Biotechnology, Inc.). The filter was
developed in 100 ml developing solution (100 mM Tris pH
9.5, 150 mM NaCl, 25 mM MgCl2) containing 675 l NBT
and 350 l BCIP (both 50 mg/ml stock solutions). For
controls, immunizing peptide (20 g/ml, Research Genet-
ics) was preincubated with antibody (1:500) for 1 h at 4°C
in blocking solution.
Cell culture
Neural crest and somite cell cultures were obtained for
immunohistochemistry. Fertile Japanese quail eggs (Co-
tournix japonica) were obtained from the Animal Sciences
Department (University of California, Davis) and incubated
at 37°C until they reached stage 15. Pieces of the trunk,
8-somites in length, were dissected from the embryos and
incubated in Pancreatin (Gibco-BRL) at 37°C until the as-
sociated somites, ectoderm, and notochord began to loosen
(a few minutes). Any remaining tissues were teased away
from the neural tube with tungsten needles. The neural tube
and somites were cultured separately on glass coverslips
(Fisher) in F-12 medium (Gibco-BRL) supplemented with
3% chick embryo extract, 10% fetal bovine serum, 100
units/ml penicillin/streptomycin, and 2 mM L-glutamine
(Gibco-BRL). After 6 h, the neural tubes were removed so
that only the earliest outgrowth of neural crest cells re-
mained in the culture. These neural crest cells will differ-
entiate into neurons and glial cells (Henion and Weston,
1994; Jin et al., 2001). The neural tubes were replated onto
new coverslips for an additional 42 h. At this time, clusters
of neural crest cells were removed from the neural tubes and
cultured separately. One hundred percent of these cells will
differentiate into pigment cells (Loring et al., 1981). The
neural tubes were also removed from the coverslips and the
remaining neural crest cells were maintained in culture for
an additional 96 h. Somites were maintained in culture
without perturbation. The cell cultures (on glass coverslips)
were washed in 37°C PBS and then fixed in ice-cold acetone
for 3 min. The coverslips were washed and immunohisto-
chemistry was performed as described below.
Immunohistochemistry
Fertile White Leghorn (Gallus gallus domesticus) eggs
(Golden Eggs, Sacramento, CA) were incubated at 37°C,
and embryos were collected at the appropriate developmen-
tal stages. Embryos were fixed for 15 min to 2 h in 100%
acetone or Carnoy fixative at 4°C. They were then rinsed
several times in PBS, infiltrated with 20% sucrose overnight
at 4°C, and embedded in Tissue Tek (Fisher). Fifteen-
micron cryosections were cut and dried at room temperature
overnight on poly-L-lysine-coated slides (POLY-PREP,
Sigma).
All washes were performed with PBSTx (PBS  0.2%
Triton X-100). Sections were blocked and antibodies di-
luted in PBSTx containing 2% BSA (Sigma). After washing
followed by a 30-min block, the sections were incubated
with ADAM 10 antibody (1:200) for either 2 h at room
temperature or overnight at 4°C. The antibody was then
washed off, and the slides blocked again for 30 min at room
temperature. Sections were incubated next in Alexa 488
conjugated goat anti-rabbit secondary antibody (1:2000;
Molecular Probes) for 30 min at room temperature. The
slides were washed extensively at room temperature and
mounted using Gel/Mount (Fisher). For control slides, the
immunizing peptide (50 g/ml, Research Genetics) was
preincubated with antibody (1:200) for 1 h at 4°C in block-
ing solution.
Immunoprecipitation
Embryonic day 11 chick brains were immunoprecipi-
tated using the human ADAM 10 antibody (Chemicon),
following the protocol described by Hattori et al. (2000).
Proteins were eluted from Protein A-Sepharose beads (Am-
ersham Pharmacia) in 2 SDS sample buffer at 50°C for 10
min, separated by SDS–PAGE, and transferred to PVDF
membrane. Antibody blotting was performed as described
for Western blotting.
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Zymography
Adult chicken glycoproteins were purified as described
for Western blotting. Immunoprecipitated protein was
eluted in zymogram sample buffer (Bio-Rad) for 10 min at
50°C. Protein was electrophoresed on a 10% gel containing
gelatin (Bio-Rad). The gel was then incubated in renatur-
ation buffer (Bio-Rad) at room temperature for 30 min and
transferred to development buffer (Bio-Rad) at 37°C over-
night. Finally, it was stained with Coomassie blue,
destained, and dried. For inhibitor studies, EDTA (20 mM)
or 1,10 phenanthroline (20 mM) was added to renaturation
and development buffers.
Functional studies
Morpholino antisense oligos were used to knockdown
ADAM 10 (Kos et al., 2001, 2003; Tucker, 2001). Morpho-
linos (500 M; GeneTools) were added to room-tempera-
ture pluronic F127 prill surfactant (pluronic gel) beads
(BASF Corp.) and then placed on ice for 1 h. Chicken eggs
were windowed and the vitelline membrane removed; then
the morpholino gel slurry (0.5 l) was layered on top of the
embryo in ovo. The eggs were sealed with tape and incu-
bated 24 h. Embryos were fixed overnight in 4% parafor-
maldehyde, followed by paraffin embedding. Twelve-mi-
cron sections were observed under fluorescent light to
visualize the morpholino label.
A metalloprotease-mutant construct of ADAM 10 was
generated by mutating the metalloprotease active-site glu-
tamic acid (E385) to an alanine (A) using the QuikChange
Site-Directed Mutagenesis Kit (Stratagene). The mutant
PCR product was cloned into pCRII (Invitrogen) and then
digested with EcoR1 and ligated into the pIRES2-EGFP
expression vector (Clontech). Chick embryos (stage 7–11)
were lifted off the yolk using filter paper rings (Chapman et
al., 2001) and placed on an agar dish in which an electrode
was embedded. The mutant ADAM 10–IRES2 or control
IRES2 DNA was then microinjected just under the vitelline
membrane. A second electrode was then placed on top of
the embryo and 2–6 mV pulses were applied using a BTX
electroporation unit. Chick embryos were then maintained
in whole-embryo culture (Chapman et al., 2001) for 24 h.
Embryos were fixed in 4% paraformaldehyde overnight,
followed by paraffin embedding.
Fig. 3. Characterization of mRNA expression during development. Whole-
mount in situ hybridization was performed with an ADAM 10 riboprobe.
After development and postfixation, embryos were embedded and 30-M
cryosections were cut. (a) Stage 13 trunk. Expression is highest in the heart
endocardium (enc) and myocardium (myo). Lower expression is seen in the
dorsal neural tube, pharynx (ph), and ectoderm. dm, dermamyotome; nt,
neural tube. (b) Stage 21 trunk. ADAM 10 mRNA is observed in the dorsal
neural tube, dermatome (dt), and myotome (mt), dermis (de), and in the
mesonephros (mes). (c) Stage 23 trunk. Expression persists in the dorsal
neural tube, dermis, myotome, and mesonephros. (d) Control embryo,
showing little nonspecific hybridization.
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To assess tissue identity, we used N-Cadherin as a
marker for neural epithelium (Duband et al., 1988). N-
Cadherin immunohistochemistry was performed with a
mouse monoclonal antibody (Sigma), diluted at 1:300, fol-
lowed by a goat anti-mouse Cy-3-conjugated secondary
antibody (Jackson), diluted at 1:500. Washing and blocking
were performed as described for ADAM 10 immunohisto-
chemistry, using PBS in place of PBSTx, and 1% BSA to
block.
Results and discussion
Cloning of chick ADAM 10
To obtain the chick ADAM 10 orthologue, we performed
RT-PCR with degenerate primers based on mammalian
ADAM 10 and Drosophila kuz sequences. Alignment of
these cDNAs demonstrated that the disintegrin domain was
a highly conserved region and was therefore optimal for
primer design. Embryonic day 9 chick brain cDNA was
amplified using nested degenerate primers located in the
disintegrin domain. In the first round of amplification, a
521-bp product was expected based on the mammalian
ADAM 10 sequences. A single band of this size was ob-
tained in the initial round of PCR. This PCR product was
then used as a target for a second round of PCR, using the
nested primer and a higher annealing temperature. This
second amplification yielded a band of 410 bp, which was
the expected size product for this PCR reaction. The DNA
was cloned into the pCRII vector and sequencing proved
this clone to be the chick ADAM 10 orthologue.
To obtain the full-length sequence of chick ADAM 10,
we performed RACE-PCR on embryonic day 11 chick brain
cDNA. The initial 5 and 3 primers utilized for RACE-PCR
were based on the chick ADAM 10 clone obtained by de-
generate RT-PCR. Several primers and RACE-PCR reac-
tions were required to obtain the entire 2250-bp chick
ADAM 10 cDNA sequence.
Chick ADAM 10 is 749 amino acids in length, with a
predicted molecular weight of 84.7 kDa. A signal sequence
precedes the prodomain. The prodomain contains a cysteine
at amino acid 173, which is conserved with other ADAM
family members, and may serve as a “cysteine switch” to
regulate metalloprotease activity. A furin cleavage site
(RKKR) lies at the boundary between the pro- and metal-
loprotease domains, where the full-length ADAM 10 pro-
tein is processed to yield the active metalloprotease. The
metalloprotease domain (amino acids 215–456) is highly
conserved with other ADAM 10 homologs, with an active
site (HEVGHNFGSPHD) that is 100% conserved with the
bovine and mouse ADAM 10 metalloprotease sequences
(Fig. 1).
The chick ADAM 10 disintegrin domain (amino acids
457–551) contains several conserved cysteines, which are
characteristic of the ADAMs. ADAM 10 does not contain
an RGD site within its disintegrin domain, which is true for
most ADAM family members. The 122 amino acid cys-
teine-rich region lies between the disintegrin and transmem-
brane domains and also displays a conservation of cysteine
residues. The cytoplasmic domain is proline-rich, which
suggests it may have binding sites for SH3 domain-contain-
ing signaling proteins.
ADAM 10 mRNA expression
Northern blotting was performed with RNA extracted
from whole chick embryos at day 2, 3, 4, and 5, and from
day 5 and day 10 eye, day 10 brain, day 10 heart, and from
quail melanoblast cultures. A chick ADAM 10 probe hy-
bridized to two major transcripts, at 4.5 and 2.8 kb (Fig. 2a).
Fig. 4. Western blot and immunoprecipitations with anti-ADAM 10 anti-
bodies. (a) Western blot with the human ADAM 10 antibody performed on
adult chick glycoproteins. A band is apparent at 82 kDa. (b) Control
Western blot with no primary antibody. (c, d, e) Immunoprecipitations
were performed on embryonic day 11 chick brain extracts with the human
ADAM 10 antibody. The precipitated proteins were then separated by
SDS–PAGE and transferred to a membrane. The membrane was blotted
with antibody as follows: (c) human ADAM 10 antibody, (d) chick ADAM
10 antibody, (e) human antibody preincubated with its immunizing peptide
(20 g/ml). Blots (c) and (d) have bands at 110, 82, and 55 kDa. Addition
of immunizing peptide abolishes the 110- and 82-kDa bands (e).
Fig. 5. Immunolocalization of ADAM 10 protein. Cross sections of chick embryos stained with the human ADAM 10 antibody and Alexa 488 conjugated
secondary antibody. (a) Stage 13 trunk. Label is strongest in the ectoderm (ec) and the basement membrane underlying the ectoderm (arrowheads). Light
labeling is found near the basal lamina of the dorsal neural tube (nt) and in endoderm (en). dm, dermamyotome. (a) Magnification of the indicated area in
(a), showing concentration of ADAM 10 protein in the basement membrane. (b) Stage 17 trunk. ADAM 10 immunoreactivity is observed in the dermis (de),
ectoderm, and mesonephros (mes). mt, myotome. Some labeling is seen near the basal lamina of the dorsal and ventrolateral neural tube. (c) Stage 20 trunk,
illustrating ADAM 10 expression in the dermis as well as in the ectoderm. (d) Stage 21 trunk. ADAM 10 expression continues in the ectoderm, dermis, and
mesonephros. Expression is also observed in the dorsal root ganglia (drg) and in the ventral neural tube where motor neurons are differentiating. (e) Stage
25 trunk. Expression continues in the ectoderm, dispersing dermis, and dorsal root ganglia. At this stage, strong ADAM 10 labeling is observed in the ventral
root motorfibers (vr) and the myotome. Expression is also apparent in endothelial cells (et). (f) Stage 25 trunk, ADAM 10 antibody was preincubated with
immunizing peptide (50 g/ml).
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The 4.5-kb transcript was present in all RNA populations
tested, although at lower levels in day 10 heart and mela-
noblast RNAs. The 2.8-kb transcript is expressed at higher
levels in day 3, 4, and 5 chick tissues. The presence of two
ADAM 10 transcripts may be due to different length 5 and
3 UTR regions or alternative splicing of ADAM 10. Al-
though fairly high stringency conditions were utilized for
the Northern blotting experiments, we cannot eliminate the
possibility that the smaller 2.8-kb band is a closely related
ADAM family member.
Whole-mount in situ hybridization was performed on
chick embryos of various stages, followed by sectioning of
the embryos to visualize the label. At stage 13, ADAM 10
mRNA is expressed mainly in epithelial tissues, notably the
endodermally derived pharynx, the dorsal neural tube, and
is particularly highly expressed in the myocardium and
endocardium of the heart (Fig. 3a). Later in development,
expression of ADAM 10 is more widespread and is espe-
cially prominent in epithelial tissues, including the epithe-
lial ectoderm, dorsal neural tube, dermis, myotome, gut
endoderm, and mesonephros (Fig. 3b and c).
ADAM 10 western blot analysis
A peptide antibody to human ADAM 10 was utilized to
determine protein distribution. This antibody corresponds to
amino acids 732–748 of the cytoplasmic domain of human
ADAM 10 (PQRQRPRESYQMGHMRR). Chick ADAM
10 varies from human ADAM 10 by only one amino acid in
this region (H in place of R in final amino acid position).
To determine the specificity of this antibody, a Western
blot was performed using adult chicken brain glycoproteins.
The human ADAM 10 antibody detects one band on the
Western blot, at 82 kDa (Fig. 4a). Based solely on amino
acid sequence, the full-length chick ADAM 10 protein lack-
ing its signal peptide, but including the prodomain, is pre-
dicted to be 82.7 kDa. The 82-kDa band observed on the
Western blot is likely to be the glycosylated form of the
active metalloprotease (lacking the prodomain). Preincuba-
tion of the antibody with its corresponding immunizing
peptide abolished all antibody binding on the blot (data not
shown).
Fig. 6. Expression of ADAM 10 protein during organogenesis. Cross sections of chick embryos were immunolabeled with the human ADAM 10 antibody
and Alexa 488 conjugated secondary antibody. (a) Stage 16 heart. Expression is observed in the heart endocardium (enc) and myocardium (myo). (b)
Magnification of the indicated area in (a), showing ADAM 10 immunolocalization in the endocardial cushion cells (enc). (c) Stage 19 heart. Expression is
observed in the endoderm (en), endocardium, and myocardium and is now observed in the proepicardium (pe), as seen in higher magnification in (d). sv, sinus
venosus; ot, outflow tract. (e) Stage 20 gut endoderm expresses ADAM 10. (f ) Stage 20 heart, illustrating epicardial (ep) expression of ADAM 10, shown
in higher magnification in (g). bc, bulbus cordis; at, atrium. (h) Stage 20 branchial arches. ADAM 10 protein is found in both the ectodermal (ec) and the
endodermal (en) layers of the branchial arches. (i) Stage 23 trunk with ADAM 10 expression observed in the ectoderm (ec) and mesonephros (mes). nt, neural
tube. (j) Stage 23 heart. ADAM 10 expression is retained as epicardial migration continues. li, liver; ve, ventricle. (k) Higher magnification of indicated area
in (j), illustrating epicardial expression of ADAM 10. (l) Stage 23 liver expresses ADAM 10.
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Fig. 7. ADAM 10 immunohistochemistry of cultured cells. (a) Early outgrowth neural crest cells. Only neuronal and glial precursors are present in this cell
population. (b) Mixed outgrowth neural crest cells. This culture contains neuronal, glial, and melanocyte precursor cells. (c) Neural crest cell clusters. A pure
population of melanoblasts and differentiated melanocytes. (d) Bright field of (c) showing differentiated melanocytes. (e) Six day mixed neural crest cell
culture. ADAM 10 is expressed by axons in culture. (f) Somites in culture. ADAM 10 is expressed in the somite, with enhanced expression at points of contact
with the substratum.
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Immunoprecipitations with subsequent Western blotting
were also performed with the human ADAM 10 antibody.
Proteins immunoprecipitated from embryonic day 11 chick
brains were separated by SDS–PAGE followed by Western
blotting with the human ADAM 10 antibody. Three bands
were detected in the blots, at 110, 82, and 55 kDa (Fig. 4c).
The 110- and 82-kDa bands were abolished when the blot-
ting antibody was preincubated with the immunizing pep-
tide (Fig. 4e), suggesting these bands are chick ADAM 10.
The 110-kDa band is most likely the glycosylated full-
length ADAM 10 protein (containing the prodomain). The
55-kDa band remained when peptide was added; this band
is likely the heavy chain of the IgG molecule, which has a
molecular weight of 55 kDa (Harlow and Lane, 1999).
To test antibody specificity, we immunoprecipitated day
11 chick brains with the human ADAM 10 antibody fol-
lowed by Western blotting with a chick ADAM 10 anti-
body. Three bands were apparent on the filter at 110, 82, and
55 kDa (Fig. 4d). These bands are the same size as those
detected by the human ADAM 10 antibody. When the chick
ADAM 10 antibody was preincubated with its immunizing
peptide, only the 55-kDa band remained on the blot (data
not shown).
Localization of ADAM 10 protein
The human ADAM 10 antibody was used to determine
protein distribution in embryonic tissue sections. Preincu-
bation of the ADAM 10 antibody with immunizing peptide
significantly reduced antibody labeling on tissue sections
(Fig. 5f).
Epithelial tissues
At stage 13, ADAM 10 protein is present in the extraem-
bryonic membranes, blood vessels (endothelia), and the
endoderm (Fig. 5a). ADAM 10 is also produced by the
ectoderm, where it is concentrated near the basal lamina
(Fig. 5a and 5a). These epithelia express ADAM 10
throughout the developmental stages examined.
Somite
During somite development, ADAM 10 expression is
limited to the dermamyotome and its derivatives (Fig. 5a–
e). ADAM 10 protein is highly expressed at the dorsal lip of
the dermamyotome and in the dispersing dermis (Fig. 5b–
d). By stage 25, higher expression levels are also observed
in the myotome, and expression remains, albeit diminished,
in the dispersing dermis (Fig. 5e). The expression of ADAM
10 in the dermamyotome suggests it may have a functional
significance during the EMT, which occurs during myotome
and dermis formation.
Heart
We first observed ADAM 10 protein in the heart at stage
16, where it is found in both the myocardium and the
endocardium (Fig. 6a and b). The endocardial cushion cells
are derived from the endocardium by undergoing an EMT at
stage 17 (Kinsella and Fitzharris, 1980). In vitro experi-
ments suggest that metalloprotease activity is crucial to this
EMT and that proteolytic degradation of collagen IV is
required for the transition to occur (Song et al., 2000).
Matrix metalloproteinase-type 2 (MMP-2) is expressed by
endocardial cushion cells before and during their migration
(Cai et al., 2000; Song et al., 2000); however, MMP-2-
deficient mice appear to undergo normal cardiac develop-
ment (Itoh et al., 1997). Thus, additional metalloproteases
are likely required during normal cardiac cushion develop-
ment. ADAM 10’s ability to cleave collagen IV (Millichip
et al., 1998) may play a significant role in this process.
At stage 19, ADAM 10 is still expressed both in myo-
cardium and in endocardial cushion cells and is now ob-
served in the proepicardium (Fig. 6c and d). The proepicar-
dium arises between the sinus venosus and the developing
liver and migrates as an epithelial sheet, the epicardium, to
cover the myocardial layer of the heart (Ho and Shimada,
1978; Viragh et al., 1993). Expression of ADAM 10 is
sustained as the epicardium continues to spread (Fig. 6f, g,
j, and k). Studies from mutant mice have demonstrated that
epicardial morphogenesis requires both VCAM-1 and 4
integrin (Kwee et al., 1995; Yang et al., 1995), illustrating
the importance of cell–cell and cell–matrix interactions
during this process. ADAM 10 may serve an adhesive role
in this process, by interacting with integrins on cells that
serve as a substratum for epicardial spreading. Additionally,
metalloprotease activity may be essential for the epibolic
movements of this epithelium. ADAM 10 is therefore ex-
pressed in two motile cell populations — the endocardial
cushion cells and the epicardium — during heart develop-
ment.
Other
ADAM 10 protein is also observed in the epithelial
lining of the gut (Fig. 6e), and in the epithelial components
of the liver (Fig. 6l) and kidney (Fig. 6i), as well as in the
endodermal and ectodermal layers of the branchial arches
(Fig. 6h). Expression of ADAM 10 in several developing
epithelial tissues suggests this protein may play a role in
epithelial morphogenesis. It was recently shown that
ADAM 10 is involved in the shedding of the L1 adhesion
molecule (Mechtersheimer et al., 2001), a protein expressed
by certain epithelia, and required for kidney tubule devel-
opment in vitro (Debiec et al., 1998).
Although ADAM 10 expression is observed in the dorsal
neural tube by in situ hybridization, immunohistochemistry
does not reveal significant protein at stage 13. Protein ex-
pression is observed in the dorsolateral and ventrolateral
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neural tube near the basal lamina after stage 18 (e.g. Fig.
5c). By stage 21, significant protein is expressed by differ-
entiating neurons of the dorsal and ventral neural tube (Fig.
5d). Tissues of the developing peripheral nervous system
begin to express ADAM 10 around stage 21 (Fig. 5d).
ADAM 10 protein is especially prevalent in the dorsal root
ganglia and ventral root motor fibers (Fig. 5e), and this
expression continues through stage 25, the latest stage ex-
amined in this study. Expression of ADAM 10 in these
developing axon bundles suggests a role during axon out-
growth. ADAM 10 regulates the cleavage of the L1 adhe-
sion molecule, which is required for axon guidance during
vertebrate development (Cohen et al., 1998; Dahme et al.,
1997). In addition, ADAM 10 cleaves ephrin A2, which also
plays a role in axon patterning by causing a collapse re-
sponse of growth cones. When mouse hippocampal neurons
are confronted with cells expressing a cleavage-inhibiting
mutant form of ephrin A2, there is a delay in the axon
collapse response when compared to wild-type ephrin A2
(Hattori et al., 2000).
Neural crest
We confirmed the expression of ADAM 10 in cultured
neural crest and somite cells. Mixed crest cultures (both
neuronal and nonneuronal cell types) and melanoblast cul-
tures all labeled with the chick ADAM 10 antibody (Fig.
7a,b, and c). Cultures containing motor axons derived from
the neural tube also displayed ADAM 10 immunoreactivity
(Fig. 7e). RT-PCR with chick ADAM 10 specific primers
confirmed expression of ADAM 10 mRNA in cultures of
early outgrowth neural crest cells as well as melanoblasts
(data not shown). Somite cells in culture also express
ADAM 10 (Fig. 7f), with a concentration of the protein in
areas of contact with the substratum. Immunohistochemis-
try on tissue sections was performed to determine if mela-
noblasts express ADAM 10 in vivo, but we were unable to
illustrate unequivocally that individual neural crest cells
were ADAM 10 positive owing to the high levels of ADAM
10 expression in the ectoderm and dermis through which the
melanoblasts migrate.
ADAM 10 metalloprotease activity
Zymography was performed to determine if chick
ADAM 10 has metalloprotease activity. Glycoproteins from
adult chicken brains were separated on a zymogram gel
containing gelatin. After development, a lytic band at 82
kDa was detected on the gel. Addition of the metallopro-
tease inhibitors EDTA (20 mM) or 1,10 phenanthroline (20
mM) abolished all protease activity on the zymogram (data
not shown).
To establish the identity of ADAM 10 in the lytic band
observed in the zymogram, duplicate samples of adult
chicken brain glycoproteins were separated on a zymogram
gel. The gel was then cut in half, and one side processed as
a zymogram (Fig. 8a), while the other side was transferred
to a membrane and blotted with the chick ADAM 10 anti-
body (Fig. 8b). The simultaneous Western blot showed a
band at 82 kDa.
To demonstrate the presence of ADAM 10 metallopro-
tease activity in embryonic tissue, an immunoprecipitation
with the human ADAM 10 antibody was performed on
embryonic day 11 chick brain tissue. The eluted protein was
electrophoresed on a zymogram gel, where protease activity
was again observed at 82 kDa (Fig. 8c). These data strongly
suggest that chick ADAM 10 has metalloprotease activity.
ADAM 10 functional studies
To determine the importance of ADAM 10 activity dur-
ing embryogenesis, we examined the role of ADAM 10 in
the development of the ectoderm. First, we utilized mor-
pholino antisense oligos, which block protein translation,
generated against ADAM 10. The morpholinos were mixed
into a pluronic gel slurry and applied on top of the ectoderm.
After 24 h, we observed a dramatic thickening of the ecto-
derm in the regions where the morpholino had penetrated
the ectoderm (Fig. 9a, b, and c).
To further examine the role of ADAM 10 in the devel-
opment of the ectoderm, we utilized a dominant-negative
construct of ADAM 10 in which the active site E385 has
been altered to an A. Evidence from other systems has
shown that expression of this construct will block ADAM
10 metalloprotease function (Pan and Rubin, 1997). We
expressed this construct in the ectoderm of stage 7–11
embryos by electroporation. After 24 h, we again saw the
characteristic thickening of the ectoderm in regions where
Fig. 8. Zymography of adult and embryonic chicken brain glycoproteins.
(a) Gelatin zymography of adult chicken brain glycoproteins reveals an
82-kDa lytic band. (b) Simultaneous Western blot performed with a du-
plicate sample from zymogram gel in (a). An identical sample as that
utilized in (a) was separated on the same zymogram gel, cut off, and
transferred to a membrane, followed by blotting with the human ADAM 10
antibody. An 82-kDa band is observed with Western blotting as well. (c)
Immunoprecipitation of embryonic day 11 chick brains with the human
ADAM 10 antibody, followed by gelatin zymography. The 82-kDa band is
also observed in immunoprecipitated protein from embryonic brain.
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the dominant-negative ADAM 10 construct was expressed
(Fig. 9d and e). Control construct (empty vector) was also
expressed in the ectoderm, but no morphological change
was observed (Fig. 9g and h).
To determine the nature of this ectodermal thickening,
we labeled the electroporated sections with an antibody to
N-Cadherin, a marker for early neural tissue. The ectoder-
mal thickening resulting from dominant-negative ADAM
10 expression was N-Cadherin positive (Fig. 9f), whereas
the ectoderm electroporated with control vector did not
express N-Cadherin (Fig. 9i). These data suggest that the
repression of ADAM 10 proteolytic activity alters the ecto-
derm from an epidermal fate to that of neural tissue. When
electroporations with the dominant-negative ADAM 10
were performed after stage 10, a dramatic decrease in N-
Cadherin labeling was observed in the ectoderm expressing
this construct. Ruffins and Bronner-Fraser (2000) have
shown that the ectoderm maintains the ability to become
neural tissue until stage 10, after which time they observed
a rapid decline in the ability of the ectoderm to express
neural markers. Expression of a dominant-negative ADAM
10 construct in Xenopus blocks lateral inhibition, resulting
in an overproduction of primary neurons (Pan and Rubin,
1997). These data support the suggestion that expression of
the dominant-negative ADAM 10 construct is altering the
ectoderm to a neuronal fate. Importantly, these studies also
suggest that metalloprotease activity is present in these early
embryonic tissues.
Fig. 9. Perturbation of ADAM 10 expression and function. (a) Phase of region of ectodermal thickening resulting from morpholino treatment. ec, ectoderm;
de, dermis. (b) Fluorescent low-magnification image of ectoderm treated with morpholino. Boxed- in region shown in higher magnification in (a) and (c).
A thickening is also observed in the extraembryonic membrane where the morpholino penetrated this tissue. nt, neural tube. (c) Fluorescence of
morpholino-treated embryo, seen in phase in (a). Morpholino is tagged with fluorescein and can be seen in the region of ectodermal thickening. (d) Phase
of embryo electroporated with dominant-negative ADAM 10. Two regions of ectodermal thickening are observed adjacent to the neural tube. (e) Fluorescence
of (d), regions of expression of the dominant-negative construct can be seen as GFP expression. (f) N-Cadherin antibody labeling of section in (d) and (e).
(g) Phase of control IRES2- electroporated embryo (no ectodermal thickening observed). (h) Fluorescent image of (g), regions of expression of control
construct are seen as GFP expression. (i). N-Cadherin antibody labeling of section in (g) and (h).
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We have cloned the first avian ADAM family member,
chick ADAM 10, and found that it is conserved with other
ADAM 10 homologs. Chick ADAM 10 is expressed in a
wide variety of tissues during development, with a high
level of expression in epithelial tissues that are undergoing
epiboly and tissues undergoing an EMT. The localization of
ADAM 10 protein to these regions in the embryo strongly
suggests that ADAM 10 plays a role in morphogenesis of
epithelial tissues during development. We have further
shown that ADAM 10 plays a functional role in the devel-
opment of the ectoderm, by repressing neurogenesis in this
tissue.
ADAM 10 null mice have recently been described (Hart-
mann et al., 2002), which die before embryonic day 10, and
have several defects in epithelial tissues. Somites in ADAM
10 null mice are irregular in size, being small or fused
together. The neural tube exhibits an abnormal morphology
as well. The first branchial arch is small and heart develop-
ment is retarded. We have shown that all of the tissues that
are defective in the ADAM 10 knockout mouse express
ADAM 10 protein in the avian embryo. Therefore, the avian
embryo will serve as a useful model system for further
investigation into the role of this protein during develop-
ment. Evidence from other systems supports a functional
role for ADAM 10 in modifying cell adhesions as well as in
directing cell migrations through interactions with proteins
such as ephrins. Future research will test these proposed
activities for ADAM 10 and provide further insight into the
role of this multifunctional protein.
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